@article{article, title  = {{Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial}},

 publisher = {{Elsevier BV}},

 url = {{https://eprints.whiterose.ac.uk/179870/ }},

 year = {{2021}},

 month = {{10}},

 author = {{Fennell DA and Ewings S and Ottensmeier C and Califano R and Hanna GG and Hill K and Danson S and Steele N and Nye M and Johnson L and Lord J et al}},

 doi = {{10.1016/s1470-2045(21)00471-x}},

 journal = {{The Lancet Oncology}},

 note = {{Accessed on 2025/01/03}}}